Biomarker-guided therapy for colorectal cancer: strength in complexity.
Biomarker-guided therapy for colorectal cancer: strength in complexity.
复制标题
DOI:
10.1038/s41571-019-0241-1
复制
发表时间:
2020-01
期刊:
影响因子:
--
通讯作者:
Lothe RA
中科院分区:
文献类型:
--
作者:
Sveen A;Kopetz S;Lothe RA
The number of molecularly stratified treatment options available to patients with colorectal cancer (CRC) is increasing, with a parallel increase in the use of biomarkers to guide prognostication and treatment decision making. This increase in both the number of biomarkers and their use has resulted in an increasingly complex situation, which is evident both from the extensive interactions between biomarkers and from their sometimes complex associations with patient prognosis and treatment benefit. Current and emerging biomarkers also reflect the genomic complexity of CRC, and include a wide range of aberrations such as point mutations, amplifications, fusions and hypermutator phenotypes, in addition to global gene expression subtypes. In this Review, we provide an overview of current and emerging clinically relevant biomarkers and their role in the management of patients with CRC, illustrating the intricacies of biomarker interactions and the growing treatment opportunities created by the availability of comprehensive molecular profiling.
登录
查看更多内容
影响因子:
3.8
作者:
Adenis A;de la Fouchardiere C;Paule B;Burtin P;Tougeron D;Wallet J;Dourthe LM;Etienne PL;Mineur L;Clisant S;Phelip JM;Kramar A;Andre T
通讯作者:
Andre T
影响因子:
8.8
作者:
Bramsen, Jesper Bertram;Rasmussen, Mads Heilskov;Andersen, Claus Lindbjerg
通讯作者:
Andersen, Claus Lindbjerg
影响因子:
8.4
作者:
Bokemeyer, Carsten;Van Cutsem, Eric;Koehne, Claus-Henning
通讯作者:
Koehne, Claus-Henning
影响因子:
45.3
作者:
Ballman, Karla V.
通讯作者:
Ballman, Karla V.
影响因子:
45.3
作者:
Bertagnolli, Monica M.;Niedzwiecki, Donna;Redston, Mark
通讯作者:
Redston, Mark